Skip to content

Author

Rui-Kang Luo

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Small-Molecule Drugs Approved by the FDA in 2025

In today’s pharmaceutical sector, innovation is not only the core driver of industry upgrading, but also closely tied to patient health and well-being. A drug’s innovative mechanism of action, physiological effects, chemical structure, and indications collectively reflect both its clinical therapeutic value and the nov...

Xiao-Yue Wang, Ying Wang, Rui-Kang Luo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.